More on RADX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $4.39 |
|
|||
| Open | $4.28 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $4.37 | ||||
| Day Low | $4.13 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 22,979 | ||||
- H.C. Wainwright Starts Radiopharm Theranostics (RADX) at Buy
- Form 6-K Radiopharm Theranostics For: Jun 03
- A Cancer Antigen Long Thought Untouchable Is Suddenly the Hottest Target in Oncology
- Form 3 Radiopharm Theranostics For: Mar 18 Filed by: Voliotis Dimitris
- Form 3 Radiopharm Theranostics For: Mar 18 Filed by: HOPPER PAUL
- Form 3 Radiopharm Theranostics For: Mar 18 Filed by: Laurita Aaron James
- Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing
- International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on April 28, 2026
- Radiopharm Theranostics Reports Business Update
- Radiopharm presents early trial data for HER2-targeted cancer therapy
Entities mentioned with RADX
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Twitter | View Related Stories »
- Deutsche Bank | View Related Stories »
- Earnings | View Related Stories »
- S1 | View Related Stories »
- Show More...
